View Older Stories View More Recent Stories

Dec 27, 2024 09:01AM Vor Biopharma (VOR) Announces $55.6M Placement
Dec 27, 2024 09:00AM Vor Bio Announces $55.6 Million Private Placement
Dec 20, 2024 09:01AM Monopar Therapeutics (MNPR) Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
Dec 20, 2024 09:00AM Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
Dec 17, 2024 08:00AM Indapta Therapeutics Secures $22.5 Million to Advance Clinical Trials of Innovative Cancer and Autoimmune Treatments
Dec 11, 2024 06:16PM RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie
Dec 8, 2024 09:00PM Be Biopharma Unveils BeCoMe-9 Trial and Presents on Versatile B Cell Medicines Platform at ASH 2024
Dec 6, 2024 05:31PM Form SC 13G Alector, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 5, 2024 06:56PM Form SC 13G Kura Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 26, 2024 05:33PM Form SC 13D/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 25, 2024 07:00AM Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline
Nov 22, 2024 04:12PM Form SC 13G Arcellx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 21, 2024 10:46AM The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development
Nov 21, 2024 08:32AM Cidara Therapeutics (CDTX) Announces $105 Million Private Placement
Nov 21, 2024 08:30AM Cidara Therapeutics Announces $105 Million Private Placement
Nov 19, 2024 11:33AM Synapticure Raises $25 Million Series A to Expand Virtual Care for Patients and Caregivers Living with Neurodegenerative Diseases in all 50 States
Nov 18, 2024 08:19PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 18, 2024 08:11AM Aclaris Therapeutics (ACRS) Announces 35.56M Share Offering at $2.25/sh
Nov 18, 2024 08:10AM Aclaris Therapeutics Announces $80 Million Private Placement
Nov 15, 2024 05:05PM Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A RxSight, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A SERA PROGNOSTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:47PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Tourmaline Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Praxis Precision Medicin Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Third Harmonic Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Tenaya Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Alto Neuroscience, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Enliven Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Structure Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Astria Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 05:46PM Form SC 13G/A Apogee Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2024 04:34PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 14, 2024 09:00AM Adela to Present Biological Insights into its Tissue-Agnostic Assay for Molecular Residual Disease Detection at the AACR Special Conference in Cancer Research
View More Recent Stories View Older Stories